𝔖 Bobbio Scriptorium

✦ LIBER ✦

PCV90 Development of an Institutional Cost of Care Model for Anticoagulation Management of Patients with Warfarin Versus Novel Oral Agents

✍ Scribed by L.T. Pizzi; L. Thomson; E. Jutkowitz; F.R. Vogenberg; B. Swift; G. Merli

Book ID: 119310651
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 61 KB
Volume: 14
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2011.08.810

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dabigatran versus warfarin under standar

Dabigatran versus warfarin under standard or pharmacogenetic-guided management for the prevention of stroke and systemic thromboembolism in patients with atrial fibrillation: a cost/utility analysis using an analytic decision model

✍ Nshimyumukiza, Léon; Duplantie, Julie; Gagnon, Mathieu; Douville, Xavier; Fourni 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 276 KB

PUK15 a Managed Care Cost-Offset Model f

PUK15 a Managed Care Cost-Offset Model for Ferric Citrate, an Experimental Phosphate Binder That Can Reduce the Use of Erythropoiesis-Stimulating Agents and Intravenous Iron in Hemodialysis Patients with Hyperphosphatemia

✍ R. Mutell; J.L. Rubin; T.C. Bond; T. Mayne 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB